Doctor Juha Koskenvuo

Turku University Hospital, Turku (Finland)

Follow

Contributor content

JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities

Presentation

JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities

ESC 365 is supported by

novartis

Explore sponsored resources